Product
Supplier
Encyclopedia
Inquiry
Home > News > Company Dynamic
ECHEMI chemical news

Company Dynamic

Titanium Dioxide Prices Soar! LB Group Raises Prices Abroad by $100/ton, Boosting Sector by 3%, GPRO Investment Group Industries Leads Rally with a Stock Market Closure

Titanium Dioxide Prices Soar! LB Group Raises Prices Abroad by $100/ton, Boosting Sector by 3%, GPRO Investment Group Industries Leads Rally with a Stock Market Closure

2024-09-05

In the context of the current economic situation, some industry leaders have actively taken measures to stabilize the supply chain and ensure the stability of the supply chain and the rationality of prices.

PSE Group Acquires RMS Pro Finishes, Automotive Refinish Distributor

PSE Group Acquires RMS Pro Finishes, Automotive Refinish Distributor

2024-09-05

PSE Group, a provider of automotive refinish and specialty coatings solutions, announces the acquisition of RMS Pro Finishes, a provider of high-quality automotive refinish and related products.

Saipem receives $1 billion offshore contract from Saudi Aramco

Saipem receives $1 billion offshore contract from Saudi Aramco

2024-09-05

Saipem has been awarded two offshore contracts in Saudi Arabia under its existing long-term agreement with Saudi Aramco. The total value of the two contracts is approximately $1 billion.

Evonik produces Rohacell foam in an environmentally friendly way at its Darmstadt plant

Evonik produces Rohacell foam in an environmentally friendly way at its Darmstadt plant

2024-09-05

Evonik has upgraded the production of its high-performance foam Rohacell at its main plant in Darmstadt, Germany, to use only electricity from renewable sources.

Evonik accelerates the iteration of cosmetic ingredients: switching from chemical processes to plant-based enzymatic esterification processes

Evonik accelerates the iteration of cosmetic ingredients: switching from chemical processes to plant-based enzymatic esterification processes

2024-09-05

Evonik officially opened its new production of cosmetic emollients, which are produced by enzymatic esterification, at the Steinau plant in Germany.

Pfizer Spends $43 Billion to Acquire Seagen, But Questions Arise as to Whether Its 8 New Drugs Can Save the Day

Pfizer Spends $43 Billion to Acquire Seagen, But Questions Arise as to Whether Its 8 New Drugs Can Save the Day

2024-09-04

Pfizer recently announced that it has completed the acquisition of Seagen, which specializes in antibody drug coupling agents (ADCs), for $43 billion.

ADNOC's €10 Billion Acquisition of Covestro in Limbo: $13 Billion Deal Shrouded in Uncertainty, Shares Surge 5.7% Sparking Market Buzz!

ADNOC's €10 Billion Acquisition of Covestro in Limbo: $13 Billion Deal Shrouded in Uncertainty, Shares Surge 5.7% Sparking Market Buzz!

2024-09-04

ABU Dhabi National Oil Company (ADNOC) is close to completing a comprehensive review of Covestro (1COV.DE), a move that marks a new stage in a potential deal worth up to 11.7 billion euros ($13 billion).

South Korea's Steel Giant POSCO Invests $40 Million to Break Dependence on Chinese Graphite! Aims to Produce 347,000 Tons of Graphite Annually, Challenging China's Supply Dominance!

South Korea's Steel Giant POSCO Invests $40 Million to Break Dependence on Chinese Graphite! Aims to Produce 347,000 Tons of Graphite Annually, Challenging China's Supply Dominance!

2024-09-04

According to media reports, South Korea's leading steel and battery materials producer POSCO Group, plans to invest in Tanzania's second largest natural graphite mine project.

Sephora to cut jobs in China as slowdown deepens

Sephora to cut jobs in China as slowdown deepens

2024-09-04

The beauty retailer is cutting jobs in the face of a challenging Chinese market amid falling demand. According to the LVMH unit, "less than 3%" of its 4,000 employees in China will face layoffs.

BASF completes sale of Wintershall Dea E&P business to Harbour Energy

BASF completes sale of Wintershall Dea E&P business to Harbour Energy

2024-09-04

The exploration and production (E&P) business of Wintershall Dea (excluding Russia-related activities) was transferred to Harbour Energy plc on September 3, 2024.

Mundipharma International's Chinese Subsidiary's Assets Sold at a Discount Failed, $1 Billion in Cash is Difficult to Find Buyers, Valuation Bubble Burst!

Mundipharma International's Chinese Subsidiary's Assets Sold at a Discount Failed, $1 Billion in Cash is Difficult to Find Buyers, Valuation Bubble Burst!

2024-09-03

Pharmaceutical giant Mundipharma International, part of the world-renowned Sackler Family, has failed for the second time to find a suitable buyer for its China unit in an asset disposal process restarted this year.

Indonesia-Africa Forum Reveals $3.5 Billion in Business Contracts, but Measles Outbreak Casts Shadow Over Bali!

Indonesia-Africa Forum Reveals $3.5 Billion in Business Contracts, but Measles Outbreak Casts Shadow Over Bali!

2024-09-03

The Indonesian president on Monday announced his country's intention to sign commercial contracts totaling $3.5 billion with African countries during the second Indonesia-Africa Forum in Bali.

Paint Giant PPG Resorts to ‘Selling Child to Survive’? Sells Business for $310 Million, Fate of 400 Employees Uncertain

Paint Giant PPG Resorts to ‘Selling Child to Survive’? Sells Business for $310 Million, Fate of 400 Employees Uncertain

2024-09-03

On August 29, PPG Industries, a leader in the global coatings industry, announced that after a thoughtful strategic review, it has reached an agreement to sell its silicon dioxide products business to QEMETICA Corporation for approximately $310 million.

Sinochem Group Plans to Sell $2 Billion Stake in U.S. Shale Gas, 11-Year Investment May Go to Waste, Asian Buyers Could Step In

Sinochem Group Plans to Sell $2 Billion Stake in U.S. Shale Gas, 11-Year Investment May Go to Waste, Asian Buyers Could Step In

2024-09-03

China's state-owned oil and chemicals company Sinochem plans to sell its 40% stake in a US shale gas joint venture, valuing it at more than $2bn, according to a Reuters report.

UCB sells mature Chinese business in a package, Middle East and Singapore capital jointly take over for nearly 5 billion yuan

UCB sells mature Chinese business in a package, Middle East and Singapore capital jointly take over for nearly 5 billion yuan

2024-09-03

UCB, a Belgian-based biopharmaceutical company, will sell its mature neurology and allergy business in China to Singapore-based asset management group CBC and Abu Dhabi-based investment company Mubadala for US$680 million (about 4.843 billion yuan).

Another business change! Mitsui Chemicals closes down styrene-acrylic resin and polyester resin related divisions

Another business change! Mitsui Chemicals closes down styrene-acrylic resin and polyester resin related divisions

2024-09-03

Mitsui Chemicals has decided to exit the styrene-acrylic resin and polyester resin related business for toner binders, mainly involving the ALMATEX™ and ALMASTAR™ brands.

BASF Announces Major Restructuring: Ludwigshafen Site to Cease Production of Adipic Acid and Downstream Products by 2025, Fate of 180 Employees Uncertain!

BASF Announces Major Restructuring: Ludwigshafen Site to Cease Production of Adipic Acid and Downstream Products by 2025, Fate of 180 Employees Uncertain!

2024-09-02

BASF officially announced on August 29 that as an important part of the restructuring of the integrated site in Ludwigshafen, Germany, the company has decided to stop the production of adipic acid and its related downstream products at the site.

Evonik's New Expansion of Methionine in Singapore: The Shutdown Controversy and Environmental Lies, with Annual Capacity Increased by 34,000 Tons, but Carbon Footprint Only Reduced by 6%?

Evonik's New Expansion of Methionine in Singapore: The Shutdown Controversy and Environmental Lies, with Annual Capacity Increased by 34,000 Tons, but Carbon Footprint Only Reduced by 6%?

2024-09-02

Recently, Evonik officially announced that the methionine MetAMINO production base expansion project located in Singapore has been successfully completed ahead of schedule.

Hengrui Pharmaceuticals: The Innovation Dilemma Behind the €160 Million Windfall, as the Supercarrier Struggles to Escape the Shadow of the Old Way

Hengrui Pharmaceuticals: The Innovation Dilemma Behind the €160 Million Windfall, as the Supercarrier Struggles to Escape the Shadow of the Old Way

2024-09-02

On August 21, 2024, Hengrui Pharmaceutical announced its remarkable financial results: in the half year, the company's revenue reached 13.601 billion yuan, an increase of 21.78% over the same period last year;

Johnson & Johnson's New Drug Comes Under Fire: 4.7-Point Improvement Fails to Ease the Plight of gMG Patients, Can the Efficacy Stand Up to Market Tests?

Johnson & Johnson's New Drug Comes Under Fire: 4.7-Point Improvement Fails to Ease the Plight of gMG Patients, Can the Efficacy Stand Up to Market Tests?

2024-09-02

The study was a double-blind, placebo-controlled trial that enrolled a large number of patients with AChR+, MuSK+, and/or LRP4+, who accounted for approximately 95% of the total number of patients with gMG.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.